Literature DB >> 20138370

The role of cognitive impairment in general functioning in major depression.

Bernhard T Baune1, Robyn Miller, Jordan McAfoose, Melissa Johnson, Frances Quirk, David Mitchell.   

Abstract

The association between cognitive performance and general functioning in depression is controversial. The present study evaluated the association between cognitive dysfunction and major depressive disorder (MDD, N=70) as compared with age- and gender-matched healthy controls (n=206) and its relationship to general functioning (physical and mental health quality of life, activities of daily living, and employment status) in participants with current MDD (n=26) and those with previous MDD only (n=44). Participants were assessed clinically using the Mini International Neuropsychiatric Interview (M.I.N.I.) for the depression groups and the Diagnostic Interview for Psychoses (DIP-DM) for the control group. Measures to evaluate cognition and quality of lifes comprised the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the Short Form-36 Health Survey Questionnaire, and the Activities/Instrumental Activities of Daily Living (ADL/IADL); employment status was also assessed in MDD. The results showed that a) while individuals with current depression had worse cognitive performance in all domains than healthy controls, those individuals with previous depression had lasting cognitive impairments in the domains of immediate memory and attention as compared with healthy controls; b) individuals with current depression had lower scores in the visuospatial/constructional and attention domains and the total score than individuals with previous depression; c) individuals in the depression group as a whole who were currently unemployed had significantly lower scores in all domains (except attention) of cognitive function; d) cognitive function was not related to either physical or mental quality of life or impairments of activities of daily living (ADL, IADL); e) that unemployment in previous depression was related to poor cognitive function similar to those with current depression. The results indicate that MDD may have detrimental and lasting effects on cognitive performance partly related to poorer general functioning. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20138370     DOI: 10.1016/j.psychres.2008.12.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  79 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

2.  Internally vs. externally triggered movements in patients with major depression.

Authors:  Felix Hoffstaedter; Jan Sarlon; Christian Grefkes; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-11-28       Impact factor: 3.332

3.  A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.

Authors:  Jing Wang; Yossef Goffer; Duo Xu; David S Tukey; D B Shamir; Sarah E Eberle; Anthony H Zou; Thomas J J Blanck; Edward B Ziff
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

4.  Attention/processing speed prospectively predicts social impairment 18 years later in mood disorders.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Robert N Faull
Journal:  J Nerv Ment Dis       Date:  2013-09       Impact factor: 2.254

Review 5.  Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.

Authors:  Chadi G Abdallah; Lynnette A Averill; John H Krystal
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

6.  Prescription of antidepressants and the risk of road traffic crash in the elderly: a case-crossover study.

Authors:  Ludivine Orriols; Machelle Wilchesky; Emmanuel Lagarde; Samy Suissa
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

7.  Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.

Authors:  Kevin Duff; Christopher Randolph; Adam L Boxer
Journal:  Clin Neuropsychol       Date:  2019-09-27       Impact factor: 3.535

Review 8.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

9.  Cognitive profiles and heritability estimates in the Old Order Amish.

Authors:  Ryan M Kuehner; Peter Kochunov; Katie L Nugent; Deanna E Jurius; Anya Savransky; Christopher Gaudiot; Heather A Bruce; James Gold; Alan R Shuldiner; Braxton D Mitchell; L Elliot Hong
Journal:  Psychiatr Genet       Date:  2016-08       Impact factor: 2.458

10.  Neurological and psychiatric diseases and their unique cognitive profiles: implications for nursing practice and research.

Authors:  David E Vance; Joan E Dodson; Jason Watkins; Bridgett H Kennedy; Norman L Keltner
Journal:  J Neurosci Nurs       Date:  2013-04       Impact factor: 1.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.